Skip to main content
Equibles
PVLA $152.95 +1.59%
PVLA logo
PVLA · Palvella Therapeutics, Inc.
Track PVLA — free

Use PVLA with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$152.95 +2.40 (+1.59%) At close · Sep 2
Russell 2000 member Rebalance outlook locked
Market Cap
$2.17B
Shares
14.41M
All earnings calls

Earnings call · FY2020 Q2

Palvella Therapeutics, Inc. (PVLA) Q2 2020 Earnings Call

Concluded Aug 10, 2020
Aug 10, 2020 0 turns
Period
FY2020 Q2
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue $11.25M +110.9% YoY
Diluted EPS -$7.20
Net income -$4.95M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Aug 10, 2020 10-Q report Filed Aug 10, 2020

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Customer Revenue$10.93M +131.4% YoY
Collaboration Revenue$316,000 -48.1% YoY
Full-screen source Call document

Report a Problem

Category
Description
Email (optional, for follow-up)